Skip to Content
Merck
  • Tea catechins inhibit hepatocyte growth factor receptor (MET kinase) activity in human colon cancer cells: kinetic and molecular docking studies.

Tea catechins inhibit hepatocyte growth factor receptor (MET kinase) activity in human colon cancer cells: kinetic and molecular docking studies.

Journal of medicinal chemistry (2009-10-21)
Christine A Larsen, William H Bisson, Roderick H Dashwood
ABSTRACT

Most cancer deaths result from spread of the primary tumor to distant sites (metastasis). MET is an important protein for metastasis in multiple tumor types. Here we report on the ability of tea catechins to suppress MET activation in human colon cancer cells and propose a mechanism by which they might compete for the kinase domain of the MET protein.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Gallic acid monohydrate, ACS reagent, ≥98.0%
Sigma-Aldrich
Gallic acid monohydrate, ≥99% (HPLC)
Sigma-Aldrich
(−)-Epicatechin, ≥90% (HPLC)
Sigma-Aldrich
(−)-Catechin, ≥97% (HPLC), from green tea
Sigma-Aldrich
(−)-Epicatechin gallate, ≥98% (HPLC), from green tea
Sigma-Aldrich
(−)-Epicatechin, ≥98% (HPLC), from green tea
Sigma-Aldrich
(−)-Gallocatechin gallate, from green tea, ≥98% (HPLC)
Sigma-Aldrich
(−)-Epigallocatechin, ≥95% (HPLC), from green tea
Supelco
(−)-Epigallocatechin, analytical standard
Supelco
(−)-Epicatechin, analytical standard
Sigma-Aldrich
(−)-Epigallocatechin gallate, ≥95%
Sigma-Aldrich
(−)-Epigallocatechin gallate, ≥80% (HPLC), from green tea
Sigma-Aldrich
Gallic acid, 97.5-102.5% (titration)